cvd

Guest: Vlad Vasile, M.D., Ph.D.Host: Stephen L. Kopecky, M.D. Ceramides score is a blood test used to assess the risk of heart attacks and stroke. Most patients evaluated for cardiovascular risk benefit from this test, particularly patients deemed at intermediate risk by other assessments...

Obstructive sleep apnea (OSA) is a condition that affects millions globally, causing daytime sleepiness, lack of oxygen, and higher risks of developing cardiac issues. A new randomized control trial, called the Pavlov study, evaluated the efficacy and long-term conditioning effects of a...

Educational Objectives In this activity, experts in prostate cancer discuss cardiovascular risk in patients receiving androgen-deprivation therapy (ADT). Upon completion of this activity, participants should be better able to: Evaluate the impacts of prostate cancer and ADT on...

Atrial Fibrillation You have atrial fibrillation, now what? Outline: Clinical Updates in AF AF: Final thought

In this presentation, F. Perry Wilson, MD evaluates the latest scientific statement from the American Heart Association regarding caffeine and cardiovascular disease. The analysis breaks down recent clinical evidence examining how daily coffee consumption influences long-term cardiac outcomes...

* Treatment should be embedded in structured monitoring of hematocrit, blood pressure, renal and hepatic function, and cardiac rhythm, and coupled with active management of coexisting obesity, sleep apnea, diabetes, hypertension, and dyslipidemia, each of which independently influences AF risk...

* Despite these limitations, this study provides a large-scale, head-to-head comparison of men receiving testosterone therapy with vs without evidence of hypogonadism, with up to 10 years of follow-up, race/ethnicity stratification, rigorous propensity-score matching, and complementary modelling...

* Dr. Patel emphasizes that real-world prescribing often differs from controlled trial conditions, particularly with injectable formulations that may result in higher testosterone peaks and greater hematologic effects. * Dr. Patel stresses the need for careful cardiovascular screening, patient...

* TRT does not increase MACE risk in men with confirmed organic hypogonadism when titrated to physiological levels. Non-MACE signals warrant vigilance rather than contraindication. Metabolic optimisation should precede TRT in functional hypogonadism. Individualised monitoring and careful patient...

Must listen here! Most men think erectile dysfunction is a bedroom problem and low testosterone is just a fact of getting older. This roundtable makes the case that both are early warning lights for your heart, your metabolism, and your long-term health and that ignoring them can cost...

* Clear Heart was built to solve that problem, offering direct-to-consumer self-pay access alongside physician referrals, with no 6-week hospital wait and results within 24 hours What does a cardiac CT scan actually show? In this video, Dr. Matthew Budoff - Professor of Medicine at the...

Incretin-Based Therapies Goals for Today

Most men think erectile dysfunction is a bedroom problem. It's actually one of the earliest warning signs of cardiovascular disease, capable of showing up three to five years before a heart attack.In this episode, Dr. Gabrielle Lyon sits down with Dr. Amy Pearlman, a urologist trained in...

https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423

In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: Overview • PV and ET increase the risk of both arterial and venous thrombotic...

How do you turn your patients' calcium scores into clear, personalized prevention plans?

Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed hazard ratio and 1-year outcome of major adverse cardiac events (MACE) to depending on...

Abstract INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED) affects over 70% of men with end-stage renal disease (ESRD), yet the cardiovascular safety of phosphodiesterase type 5 inhibitors (PDE5i) in this population remains poorly understood. Concerns persist due to altered...

Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed risk ratios and outcome of major adverse cardiovascular to depending on different period...

https://www.cbc.ca/listen/cbc-podcasts/410-the-dose/episode/16210375-what-can-erectile-dysfunction-say-about-mens-health Erectile dysfunction is commonly thought of as a sexual health issue, but experts say the condition can reveal a lot about men's health. Dr. Dean Elterman, a urologist at the...

https://www.nejm.org/doi/abs/10.1056/NEJMra2202438

Dr. Khera of course! * if you prescribe testosterone there are five controversies you have to know about! Mohit Khera, MD, MBA, MPH Professor of Urology F. Brantley Scott Chair in Urology Director, Laboratory for Andrology Research Faculty Group Practice Medical Director Baylor College...

Sexual medicine is underfunded, misunderstood, and often dismissed. But it's also one of the most collaborative fields in healthcare. Dr. Tami Rowen and I recap this year's ISSWSH conference and what it revealed about where the field is heading. Dr. Tami Rowen is an associate professor of OBGYN...

As we close out Black History Month, we shine a necessary spotlight on a living legend whose name deserves to be spoken with the same weight as the breakthroughs he helped create. Dr. Arthur Burnett is a world-renowned urologist whose groundbreaking research around nitric oxide pathways helped...

* Substantial evidence suggests that sleep disorders may impair testosterone levels, partially improved after specific treatments (for instance: positive airway pressure for OSA). On the other hand, appropriate indications for testosterone replacement therapy (TRT) can alleviate hypogonadism...

How often should men on TRT check their hematocrit? The standard monitoring schedule includes a baseline CBC before starting TRT, a recheck at 3 to 6 weeks, another at 3 months, and then at 6 and 12 months once stable. Any dose or formulation change resets the monitoring clock, requiring a...

Dr. Peter Wilson I am going to give you some pearls from recent talks. 1:28-2:19 * Shehzad Basaria from Harvard who's on the TRAVERSE Trial. He said one of the biggest mistakes were making is assuming free testosterone is correct. Thats important and I think we in endocrinology and urology...

Take home message

Heart disease risk isn’t just about cholesterol. In this episode of A Whole New Level, Dr. Matthew Budoff explains why coronary artery calcium (CAC) scoring may be the most important test most people aren’t getting—and why imaging your arteries directly can reveal risk that blood tests alone can...

Diagnostic Assessment Strategy: Cardiovascular Risk & Systemic Health in Hypogonadal Patients 1. Strategic Framework for Cardiovascular Risk in the Hypogonadal Male In the contemporary clinical landscape, the management of the hypogonadal male demands a multi-modal assessment strategy that...